Adam Smith Conferences

Adam Smith Conferences Adam Smith Conferences is the market leader for conferences and exhibitions.

Since 1992, Adam Smith Conferences has organized and continues to successfully organize a number of business forums that attract thousands of government and business executives every year. Many of these events are now established annual gatherings, which offer unrivalled insights into market trends and developments, investment opportunities, and commercial strategies for success. Conferences of ou

r company have provided platforms for debate across many industry sectors including: energy, transport, banking & financial services, consumer goods, real estate, investments, pharmaceuticals, mining & metals, pulp & paper, automotive, agribusiness and IT. Our events have been focusing on the markets of Western, Central and South-Eastern Europe and Asia. The consistent high quality of our events has earned a high reputation among economic and industrial leaders, who participate in our conferences, provide delegates with access to the most up-to-date and proven information about the market, and stimulate business communication.

Eurasian Pharma 2026: The Journey Starts HereWe’re excited to announce that preparation for the next Eurasian Pharmaceut...
11/06/2025

Eurasian Pharma 2026: The Journey Starts Here

We’re excited to announce that preparation for the next Eurasian Pharmaceutical Forum is officially underway!

As we begin shaping the agenda, conducting in-depth industry research, and confirming high-level speakers, we invite our community to be part of this journey from day one.

✅ Propose a topic for discussion
✅ Suggest or nominate a speaker
✅ Explore partnership opportunities
✅ Pre-register at a reduced rate

The 2026 forum promises to be our most ambitious yet — bringing together the leading minds of pharma, government, and healthcare across the EAEU and CIS.

📍 Visit eurasian-pharma.com to stay informed and get involved.

Let’s shape the future together.

Last week was packed with important events, including the Eurasian Pharmaceutical Forum. But beyond that, there were man...
11/03/2025

Last week was packed with important events, including the Eurasian Pharmaceutical Forum. But beyond that, there were many other significant developments in healthcare policy and regulation across the region.

Together with Outpost Eurasia, we present the latest weekly Healthcare Policy & Regulatory Digest for Eastern Europe, South Caucasus, and Central Asia (EECA), covering the period March 3–9, 2025.

📩 Read the Digest here: https://t.me/eurasianpharma/97

The session on "Effective Data Management in Clinical Trials: Risks, Strategies, and Regulatory Decisions" at the Eurasi...
05/03/2025

The session on "Effective Data Management in Clinical Trials: Risks, Strategies, and Regulatory Decisions" at the Eurasian Pharmaceutical Forum 2025 delved into the complexities of clinical research, focusing on data integrity, regulatory compliance, and strategic risk management.

Experts discussed best practices for handling clinical trial data, the role of digitalization in improving transparency and efficiency, and how regulatory frameworks impact research processes.

Closing the discussion, speakers expressed their optimism about the future of clinical research in the region.

A big thank you to all speakers and participants for an insightful session! The development of clinical research is a key driver for pharmaceutical innovation, and we look forward to seeing continued progress in this area.

The session on "Collaboration between Local and International Players: Strategic Partnerships to Expand Distribution and...
05/03/2025

The session on "Collaboration between Local and International Players: Strategic Partnerships to Expand Distribution and Adapt Products to Regional Markets" at the Eurasian Pharmaceutical Forum 2025 focused on the practical aspects of international cooperation in the pharmaceutical industry.

Under the moderation of Zafar Vakhidov, Counsel of APRFD KAZ & AIPM UZB, Partner of Vakhidov & Partners, experts explored how global companies can leverage partnerships with local players to accelerate product launches in EAEU countries.

A key point of debate was the legal and operational risks that may arise in international collaborations. Speakers shared insights on navigating regulatory frameworks, ensuring compliance, and mitigating challenges in cross-border partnerships.

Wrapping up the session, Zafar Vakhidov highlighted his confidence in the future of the regional market:
"I believe that, overall, the pharmaceutical industry in the Central Asian region will continue to grow in a healthy and sustainable way."

A big thank you to all speakers and participants for a productive and insightful discussion!

The Analytical Session of the Eurasian Pharmaceutical Forum 2025 brought together industry experts and regulators for an...
05/03/2025

The Analytical Session of the Eurasian Pharmaceutical Forum 2025 brought together industry experts and regulators for an in-depth discussion of pharmaceutical market trends based on analytics.

As part of the Expert Analytical Session: Overview of Pharmaceutical Markets of EAEU Countries, Results of 2024 and Forecasts for 2025, moderator Alexander Ivanov, Head of Strategic Consulting at Aston Health, opened the discussion by highlighting its importance:

"I am very pleased to open what is probably the most traditional session of our conference - an analytical session. It is a key part of every event. Today we have an exciting line-up of participants: representatives from analytical agencies who will share their insights on pharmaceutical market trends, key drivers and recent changes. We also have regulators who will discuss the latest regulatory initiatives and their impact on market dynamics.

The session was filled not only with valuable data and key takeaways but also with engaging debates.

🔹 A big appreciation to all speakers and participants for the insightful analysis and lively discussion that made this session so impactful!

The second day of the Forum agenda continues with an insightful discussion on drug labelling systems.Industry experts an...
05/03/2025

The second day of the Forum agenda continues with an insightful discussion on drug labelling systems.

Industry experts and regulators explored the impact of labelling on transparency, safety and the pharmaceutical supply chain. Speakers shared insights and results from drug labelling and traceability projects implemented in different countries, highlighting best practices and future perspectives.
The session provided a valuable platform for sharing experiences and discussing the challenges and opportunities in adapting labelling regulations.

🙏 Thank you to all speakers and participants for an engaging and insightful discussion!

Eurasian Pharmaceutical Forum 2025
hashtag hashtag

The final session of the first day of the Eurasian Pharmaceutical Forum 2025 closed with an engaging discussion on digit...
04/03/2025

The final session of the first day of the Eurasian Pharmaceutical Forum 2025 closed with an engaging discussion on digitalisation in healthcare, covering key trends in AI, telemedicine and the formation of a unified digital healthcare space.

🙏 A big thank you to all Forum participants for such valuable insights and discussions! Another exciting day of the programme ahead!

The panel session "Innovation and Patent Disputes: Balancing Intellectual Property Protection and Access to Medicines" b...
04/03/2025

The panel session "Innovation and Patent Disputes: Balancing Intellectual Property Protection and Access to Medicines" brought together industry leaders, legal experts, and regulators to discuss the complexities of pharmaceutical patents, innovation incentives, and patient access to medicines.

🙏 Thank you to all the speakers for an insightful and engaging discussion! Your expertise is invaluable in shaping the future of pharmaceutical innovation and accessibility.

Eurasian Pharmaceutical Forum 2025

The panel discussion on "Pricing in the Countries of the Eurasian Region: Challenges and Solutions for 2024-2025" brough...
04/03/2025

The panel discussion on "Pricing in the Countries of the Eurasian Region: Challenges and Solutions for 2024-2025" brought together key regulators, industry experts, and pharmaceutical representatives to address pricing policies and access to medicines.

💡 The discussion focused on pricing strategies, regulatory approaches, and access to medicines across EAEU and CIS countries, with particular attention to harmonization efforts and sustainable market solutions.

A huge thank you to all the speakers for such a dynamic and insightful discussion!

Roman Dray, Director of the Research and Development Department of ГЕРОФАРМ, shared his perspective on the regulatory pr...
04/03/2025

Roman Dray, Director of the Research and Development Department of ГЕРОФАРМ, shared his perspective on the regulatory process and the challenges associated with drug approval and registration.

"The regulatory authorities are indeed making efforts to meet us halfway. However, this takes time - six months to achieve compliance and then another year for registration through the national process.
Recognition in a country is particularly difficult for a drug that is not yet on the market there and does not have a national registration certificate. As national procedures are still in place, one way we work around this is to first register the medicine in the country and then bring it into compliance. This approach works faster because we have access to the dossier and direct communication with the applicant - that is, with us - which allows us to respond more efficiently to requests".

Eurasian Pharmaceutical Forum 2025

ARDAK TULEGENOVA, Head of the Department for the Improvement of the State Pharmacopoeia of the Republic of Kazakhstan an...
04/03/2025

ARDAK TULEGENOVA, Head of the Department for the Improvement of the State Pharmacopoeia of the Republic of Kazakhstan and the EAEU, emphasized the critical role of the EAEU Pharmacopoeia in ensuring the quality of medicines entering the market.

"The EAEU Pharmacopoeia sets the quality criteria for medicines and serves as the foundation for drug registration and examination within the union. I simply cannot imagine a situation where an expert evaluation could be conducted without this fundamental document.

I hope that this year we will finalize the fourth part of the first volume, completing the general requirements of the Pharmacopoeia. After that, we face the challenging task of developing the second volume and the complex second part dedicated to private pharmacopoeial monographs."

Eurasian Pharmaceutical Forum 2025

Talgat Momyshev, Director of the Technical Regulation and Accreditation Department, EEC, at the Eurasian Pharmaceutical ...
04/03/2025

Talgat Momyshev, Director of the Technical Regulation and Accreditation Department, EEC, at the Eurasian Pharmaceutical Forum 2025.

"The Eurasian system for drug registration is now operating at full scale, and we are witnessing a sharp increase in application submissions. The total number of applications has approached 28,000, with more than 9,000 registration certificates already issued.

At the same time, I would like to remind everyone that the transition period—along with the simplified compliance procedure compared to new registration—will end in December 2025. This deadline will not be extended."

Address

Republic Of Kazakhstan, Almaty,st. Zharokova, D. 257, Of. 201
Moscow
050012

Telephone

+74957852208

Website

Alerts

Be the first to know and let us send you an email when Adam Smith Conferences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Adam Smith Conferences:

Shortcuts

Share

Our Story

Since 1992 Adam Smith Conferences have been developing a range of high-calibre industry forums, which attract thousands of key decision makers from governments and industry each year. Many of these events are now the established annual gatherings for industry players, which offer unrivalled insights into market trends and developments, investment opportunities, and commercial strategies for success. Adam Smith Conferences have provided platforms for debate across many industry sectors including: energy, transport, banking & financial services, retail and FMCG, real estate, investments, pharmaceuticals, mining & metals, pulp & paper, automotive, agribusiness, and IT. Our experience and extensive contacts, developed over the last twenty years, have enabled us to create a highly specialised niche and we are proud that today we are the market leader for conferences in Russia and the CIS! The consistent high quality of our events has given rise to a reputation for excellence, ensuring that Adam Smith Conferences provide the most fertile ground for participants to gain up-to-the-minute market intelligence and invaluable opportunities to network and generate new business.